Initial modelling and updates on cost effectiveness from the first 10 years of a spleen registry

Sarah Luu, Penelope Jones, Ian Woolley, Denis Spelman, Lisa Gold

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Objective: To validate our estimates from our original model and re-evaluate the cost-effectiveness of Spleen Australia, the Australian post-splenectomy registry, using our original model with updated model parameters based on advances in the literature and experience of the registry over the past decade. Methods: We revisited a decision model from 2005, comparing 1,000 hypothetical registered patients with asplenia or hyposplenism against 1,000 who were not registered, and updated the model parameters. The cost-effectiveness of the registry was evaluated from a healthcare perspective in terms of additional cost per case of overwhelming post-splenectomy infection (OPSI) avoided and as additional cost per life year gained. Results: Over a cohort lifetime the registry was associated with an additional cost of $125,724 per case of OPSI avoided or $19,286 per life year gained. Conclusions: Despite our initial over-estimation of immunisation and chemoprophylaxis uptake and increases in unit costs, our re-evaluation confirmed use of the registry to be cost-effective. Implications for public health: Improved outcomes for patients with asplenia or hyposplenism can be achieved by a cost-effective registry. Additional research into effectiveness of interventions, OPSI prevalence associated with varying intervention use, and compliance rates over time after registration would provide improved accuracy of cost-effectiveness estimates.

Original languageEnglish
Pages (from-to)463-466
Number of pages4
JournalAustralian and New Zealand Journal of Public Health
Volume42
Issue number5
DOIs
Publication statusPublished - 1 Oct 2018

Keywords

  • cost-effectiveness
  • registry
  • spleen

Cite this

@article{ce9c0cbcc03e4c1b9551c2e15445439c,
title = "Initial modelling and updates on cost effectiveness from the first 10 years of a spleen registry",
abstract = "Objective: To validate our estimates from our original model and re-evaluate the cost-effectiveness of Spleen Australia, the Australian post-splenectomy registry, using our original model with updated model parameters based on advances in the literature and experience of the registry over the past decade. Methods: We revisited a decision model from 2005, comparing 1,000 hypothetical registered patients with asplenia or hyposplenism against 1,000 who were not registered, and updated the model parameters. The cost-effectiveness of the registry was evaluated from a healthcare perspective in terms of additional cost per case of overwhelming post-splenectomy infection (OPSI) avoided and as additional cost per life year gained. Results: Over a cohort lifetime the registry was associated with an additional cost of $125,724 per case of OPSI avoided or $19,286 per life year gained. Conclusions: Despite our initial over-estimation of immunisation and chemoprophylaxis uptake and increases in unit costs, our re-evaluation confirmed use of the registry to be cost-effective. Implications for public health: Improved outcomes for patients with asplenia or hyposplenism can be achieved by a cost-effective registry. Additional research into effectiveness of interventions, OPSI prevalence associated with varying intervention use, and compliance rates over time after registration would provide improved accuracy of cost-effectiveness estimates.",
keywords = "cost-effectiveness, registry, spleen",
author = "Sarah Luu and Penelope Jones and Ian Woolley and Denis Spelman and Lisa Gold",
year = "2018",
month = "10",
day = "1",
doi = "10.1111/1753-6405.12832",
language = "English",
volume = "42",
pages = "463--466",
journal = "Australian and New Zealand Journal of Public Health",
issn = "1753-6405",
publisher = "Wiley-Blackwell",
number = "5",

}

Initial modelling and updates on cost effectiveness from the first 10 years of a spleen registry. / Luu, Sarah; Jones, Penelope; Woolley, Ian; Spelman, Denis; Gold, Lisa.

In: Australian and New Zealand Journal of Public Health, Vol. 42, No. 5, 01.10.2018, p. 463-466.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Initial modelling and updates on cost effectiveness from the first 10 years of a spleen registry

AU - Luu, Sarah

AU - Jones, Penelope

AU - Woolley, Ian

AU - Spelman, Denis

AU - Gold, Lisa

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Objective: To validate our estimates from our original model and re-evaluate the cost-effectiveness of Spleen Australia, the Australian post-splenectomy registry, using our original model with updated model parameters based on advances in the literature and experience of the registry over the past decade. Methods: We revisited a decision model from 2005, comparing 1,000 hypothetical registered patients with asplenia or hyposplenism against 1,000 who were not registered, and updated the model parameters. The cost-effectiveness of the registry was evaluated from a healthcare perspective in terms of additional cost per case of overwhelming post-splenectomy infection (OPSI) avoided and as additional cost per life year gained. Results: Over a cohort lifetime the registry was associated with an additional cost of $125,724 per case of OPSI avoided or $19,286 per life year gained. Conclusions: Despite our initial over-estimation of immunisation and chemoprophylaxis uptake and increases in unit costs, our re-evaluation confirmed use of the registry to be cost-effective. Implications for public health: Improved outcomes for patients with asplenia or hyposplenism can be achieved by a cost-effective registry. Additional research into effectiveness of interventions, OPSI prevalence associated with varying intervention use, and compliance rates over time after registration would provide improved accuracy of cost-effectiveness estimates.

AB - Objective: To validate our estimates from our original model and re-evaluate the cost-effectiveness of Spleen Australia, the Australian post-splenectomy registry, using our original model with updated model parameters based on advances in the literature and experience of the registry over the past decade. Methods: We revisited a decision model from 2005, comparing 1,000 hypothetical registered patients with asplenia or hyposplenism against 1,000 who were not registered, and updated the model parameters. The cost-effectiveness of the registry was evaluated from a healthcare perspective in terms of additional cost per case of overwhelming post-splenectomy infection (OPSI) avoided and as additional cost per life year gained. Results: Over a cohort lifetime the registry was associated with an additional cost of $125,724 per case of OPSI avoided or $19,286 per life year gained. Conclusions: Despite our initial over-estimation of immunisation and chemoprophylaxis uptake and increases in unit costs, our re-evaluation confirmed use of the registry to be cost-effective. Implications for public health: Improved outcomes for patients with asplenia or hyposplenism can be achieved by a cost-effective registry. Additional research into effectiveness of interventions, OPSI prevalence associated with varying intervention use, and compliance rates over time after registration would provide improved accuracy of cost-effectiveness estimates.

KW - cost-effectiveness

KW - registry

KW - spleen

UR - http://www.scopus.com/inward/record.url?scp=85053558703&partnerID=8YFLogxK

U2 - 10.1111/1753-6405.12832

DO - 10.1111/1753-6405.12832

M3 - Article

VL - 42

SP - 463

EP - 466

JO - Australian and New Zealand Journal of Public Health

JF - Australian and New Zealand Journal of Public Health

SN - 1753-6405

IS - 5

ER -